Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.

Penzel N, Polosecki P, Addington J, Arango C, Asgari-Targhi A, Billah T, Bouix S, Calkins ME, Campbell DE, Cannon TD, Castro E, Cho KIK, Coleman MJ, Corcoran CM, Dwyer D, Frangou S, Fusar-Poli P, Glynn RJ, Haidar A, Harms MP, Jacobs GR, Kambeitz J, Kapur T, Kelly SM, Koutsouleris N, Abhinandan KR, Kucukemiroglu S, Kwon JS, Lewandowski KE, Li QS, Mantua V, Mathalon DH, Mittal VA, Nicholas S, Pandina GJ, Perkins DO, Potter A, Reichenberg A, Reinen J, Sand MS, Seitz-Holland J, Shah JL, Srinivasan V, Srivastava A, Stone WS, Torous J, Vangel MG, Wang J, Wolff P, Yao B, Anticevic A, Wolf DH, Zhu H, Bearden CE, McGorry PD, Nelson B, Kane JM, Woods SW, Kahn RS, Shenton ME, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Cecchi G, Pasternak O

Open source

DOI: 10.1038/s41537-025-00561-w
Published: 2025 Apr 3
Container: Schizophrenia (Heidelberg, Germany)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41537-025-00561-w,
  title = {Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.},
  author = {Penzel N and Polosecki P and Addington J and Arango C and Asgari-Targhi A and Billah T and Bouix S and Calkins ME and Campbell DE and Cannon TD and Castro E and Cho KIK and Coleman MJ and Corcoran CM and Dwyer D and Frangou S and Fusar-Poli P and Glynn RJ and Haidar A and Harms MP and Jacobs GR and Kambeitz J and Kapur T and Kelly SM and Koutsouleris N and Abhinandan KR and Kucukemiroglu S and Kwon JS and Lewandowski KE and Li QS and Mantua V and Mathalon DH and Mittal VA and Nicholas S and Pandina GJ and Perkins DO and Potter A and Reichenberg A and Reinen J and Sand MS and Seitz-Holland J and Shah JL and Srinivasan V and Srivastava A and Stone WS and Torous J and Vangel MG and Wang J and Wolff P and Yao B and Anticevic A and Wolf DH and Zhu H and Bearden CE and McGorry PD and Nelson B and Kane JM and Woods SW and Kahn RS and Shenton ME and Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) and Cecchi G and Pasternak O},
  year = {2025},
  journal = {Schizophrenia (Heidelberg, Germany)},
  doi = {10.1038/s41537-025-00561-w},
  url = {https://doi.org/10.1038/s41537-025-00561-w}
}

RIS

TY  - JOUR
TI  - Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.
AU  - Penzel N
AU  - Polosecki P
AU  - Addington J
AU  - Arango C
AU  - Asgari-Targhi A
AU  - Billah T
AU  - Bouix S
AU  - Calkins ME
AU  - Campbell DE
AU  - Cannon TD
AU  - Castro E
AU  - Cho KIK
AU  - Coleman MJ
AU  - Corcoran CM
AU  - Dwyer D
AU  - Frangou S
AU  - Fusar-Poli P
AU  - Glynn RJ
AU  - Haidar A
AU  - Harms MP
AU  - Jacobs GR
AU  - Kambeitz J
AU  - Kapur T
AU  - Kelly SM
AU  - Koutsouleris N
AU  - Abhinandan KR
AU  - Kucukemiroglu S
AU  - Kwon JS
AU  - Lewandowski KE
AU  - Li QS
AU  - Mantua V
AU  - Mathalon DH
AU  - Mittal VA
AU  - Nicholas S
AU  - Pandina GJ
AU  - Perkins DO
AU  - Potter A
AU  - Reichenberg A
AU  - Reinen J
AU  - Sand MS
AU  - Seitz-Holland J
AU  - Shah JL
AU  - Srinivasan V
AU  - Srivastava A
AU  - Stone WS
AU  - Torous J
AU  - Vangel MG
AU  - Wang J
AU  - Wolff P
AU  - Yao B
AU  - Anticevic A
AU  - Wolf DH
AU  - Zhu H
AU  - Bearden CE
AU  - McGorry PD
AU  - Nelson B
AU  - Kane JM
AU  - Woods SW
AU  - Kahn RS
AU  - Shenton ME
AU  - Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ)
AU  - Cecchi G
AU  - Pasternak O
PY  - 2025
JO  - Schizophrenia (Heidelberg, Germany)
DO  - 10.1038/s41537-025-00561-w
UR  - https://doi.org/10.1038/s41537-025-00561-w
ER  -

APA

N, P., P, P., J, A., C, A., A, A., T, B., S, B., ME, C., DE, C., TD, C., E, C., KIK, C., MJ, C., CM, C., D, D., S, F., P, F., RJ, G., A, H., MP, H., GR, J., J, K., T, K., SM, K., N, K., KR, A., S, K., JS, K., KE, L., QS, L., V, M., DH, M., VA, M., S, N., GJ, P., DO, P., A, P., A, R., J, R., MS, S., J, S., JL, S., V, S., A, S., WS, S., J, T., MG, V., J, W., P, W., B, Y., A, A., DH, W., H, Z., CE, B., PD, M., B, N., JM, K., SW, W., RS, K., ME, S., SCZ), A. M. P. S. (., G, C., & O, P. (2025). Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.. Schizophrenia (Heidelberg, Germany). https://doi.org/10.1038/s41537-025-00561-w

Source records

pubmed · retrieved 2026-09-26T07:56:52.890Z